All filters
Videos
Pharmacokinetics of mAbs in Prevention, Treatment and Cure of Viral Infections -Edmund Capparelli, PharmD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Optimization of Pharmacology Studies and DDIs in Pregnant and Lactating Individuals -Angela Colbers, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Pharmacology Pearls for Managing Absorption and Swallowing Difficulties - Saye Khoo, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Age-Related Changes in Pharmacokinetics and Pharmacodynamics - Catia Marzolini, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
The Non-adherent Patient: A Good or Bad Candidate for CAB+RPV? - Jose Castillo-Mancilla, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Long-acting Cabotegravir for Treatment and Prevention - M. Boffito, MD, PhD, FRCP
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Long-acting Cabotegravir for Treatment and Prevention: When Are You Protected? - M. Boffito, MD, PhD, FRCP
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
What’s on the Horizon for Direct Acting Antivirals for Hepatitis B? - Jennifer Kiser, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Recent Developments in Antivirals Against Herpes Simplex Virus Infection - Scott H. James, MD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Pharmacology Considerations of Future ART/PrEP Regimens - Marta Boffito, MD, PhD, FRCP
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Session 2: Discussion with the Audience | International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
CON Healthcare Provider: Oral Daily and/or On Demand PrEP - Laura Waters, MD, FRCP
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
PRO Healthcare Provider: Long-Acting Injectables for PrEP - Steve Taylor, MBChB, FRCP, PhD
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
#2: Pharmacokinetics of sotrovimab, a monoclonal antibody for early treatment of mild-to-moderate COVID-19 - Asma El-Zailik
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022
Videos
Managing HIV Patients with Limited Treatment Options - 2nd EU Series, Spanish Edition
Presented at:
Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition
Videos
Managing HIV Patients with Limited Treatment Options - 2nd EU Series, Italian Edition
Presented at:
Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition
Videos
Managing HIV Patients with Limited Treatment Options - 2nd EU Series, German Edition
Presented at:
Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition
Slidesets
CON Standpoint - Laura Waters, MD, FRCP
Presented at:
2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?
Slidesets
PRO Standpoint - Jürgen Rockstroh, MD
Presented at:
2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?
Videos
CON Standpoint - Laura Waters, MD, FRCP
Presented at:
2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?
Videos
PRO Standpoint - Jürgen Rockstroh, MD
Presented at:
2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?
Slidesets
Use of PROMS - Nurse's Perspective - Moses Shongwe, RN
Presented at:
Nurses & Pharmacists HIV Clinical Forum 2022